1:21
Highlights on interesting data presented at COMy 2017
Meletios Dimopoulos
1:31
How effective are current drug treatments for patients with myeloma kidney disease?
Meletios Dimopoulos
1:56
Effective antibody therapy and updates from the POLLUX and CASTER trials at IMW
Meletios Dimopoulos
1:37
Which is the best combination therapy in relapsed and refractory multiple myeloma?
Meletios Dimopoulos
1:50
Which treatments are currently available for relapsed and refractory myeloma treatment?
Meletios Dimopoulos
5:36
Daratumumab shows remarkable benefit in relapsed or refractory multiple myeloma in the POLLUX trial
Meletios Dimopoulos
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals